Table 3.
Inertia/non-inertia predictive model by linear discriminant analysis
| Non-inerts | Inerts | P-value | ||
|---|---|---|---|---|
| 1 | I agree with the French (SFR 2018) and/or European (EULAR 2019) recommendations regarding the management of psoriatic arthritis ≥9 | × | 0.0005 | |
| 2 | Time to access a consultation appointment ≥90 days | × | 0.0017 | |
| 3 | For patients with psoriatic arthritis, teleconsultation can be an alternative to face-to-face follow-up ≥7 | × | 0.0012 | |
| 4 | Number of patients with osteoarthritis ≥500 | × | 0.0035 | |
| 5 | In psoriatic arthritis, a delay in management has a negative effect on patient's prognosis ≥9/10 | × | 0.0047 | |
| 6 | Number of patients with psoriatic arthritis ≤40 | × | 0.0087 | |
| 7 | Presence of comorbidities—rarely (cause of inertia) | × | 0.0114 | |
| 8 | Lack of time in consultation—very rarely (cause of inertia) | × | 0.0203 | |
| 9 | Fear that the new treatment will be less well tolerated than the current treatment—frequently (cause of inertia) | × | 0.0317 | |
| 10 | Attended and followed the communications of any International Congress | × | 0.0325 | |
| 11 | Interest level for osteoarthritis ≥9/10 | × | 0.0964 |
SFR: Société Française de Rhumatologie.